Advisory
We make your sustainability efforts measurable, actionable & impactful
We are seasoned management consultants with extensive experience from serving established companies, institutional investors, and public institutions on their most pressing topics within strategy, organisation and sustainability. Bringing with us hands-on experience as managers and executives.
We support clients driving sustainability forward from any starting point
We are seasoned management consultants with extensive experience from serving established companies, institutional investors, and public institutions on their most pressing topics within strategy, organisation and sustainability.
Our services cover every step of the sustainability journey — from ambition to action
- Private equity and investors
- Strategy and value creation
- Reporting and regulation
- Nature and resources
- Climate
We support investors across the full investment cycle, from fund strategy and impact priorities to Due Diligence, ownership and exit. Our work helps embed sustainability and impact throughout, unlocking long-term value and stronger outcomes.
- Sustainable fundsabout /services/sustainable-fundsSustainable funds
- Private equity servicesabout /services/private-equity-servicesPrivate equity services
Our services cover every step of the sustainability journey — from ambition to action
We support investors across the full investment cycle, from fund strategy and impact priorities to Due Diligence, ownership and exit. Our work helps embed sustainability and impact throughout, unlocking long-term value and stronger outcomes.
- Sustainable fundsabout /services/sustainable-fundsSustainable funds
- Private equity servicesabout /services/private-equity-servicesPrivate equity services
Our advisory cases
We work with private companies, government institutions, investors, funds and foundations in both crafting and realising their full sustainability potential. We are industry agnostic and advise companies of varying size both in the Nordics and globally.
- EQTabout ?overlay=eqt
EQT
ESG due diligence of 3Shape investment
- Private equity servicesabout /services/private-equity-servicesPrivate equity services
- Value creation & commercialisationabout /services/value-creation-and-commercialisationValue creation & commercialisation
- CIPabout ?overlay=cip
CIP
Sustainability reporting for leading fund manager within renewable energy infrastructure
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- DSBabout ?overlay=dsb
DSB
GHG inventory and SBTi target setting and application
- Decarbonisation & transitionabout /services/decarbonisation-and-transitionDecarbonisation & transition
- Polarisabout ?overlay=polaris
Polaris
Sustainability strategy & ESG reporting benchmark in private equity
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Value creation & commercialisationabout /services/value-creation-and-commercialisationValue creation & commercialisation
- Lyngsoe Systemsabout ?overlay=lyngsoe-systems
Lyngsoe Systems
Developing a sustainability strategy and leveraging sustainability commercially for logistics software and systems player
- Value creation & commercialisationabout /services/value-creation-and-commercialisationValue creation & commercialisation
- Decarbonisation & transitionabout /services/decarbonisation-and-transitionDecarbonisation & transition
- Novo Nordiskabout ?overlay=novo-nordisk
Novo Nordisk
ESG industry reporting benchmark
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Navigare Capitalabout ?overlay=navigare-capital
Navigare Capital
Sustainability strategy and execution for fund manager of maritime assets
- Biodiversity & nature impactabout /services/biodiversity-and-nature-impactBiodiversity & nature impact
- Decarbonisation & transitionabout /services/decarbonisation-and-transitionDecarbonisation & transition
- Tivoliabout ?overlay=tivoli
Tivoli
Full Scope 1-3 GHG baseline
- Decarbonisation & transitionabout /services/decarbonisation-and-transitionDecarbonisation & transition
- Sustainability strategy & organisationabout /services/sustainability-strategy-and-organisationSustainability strategy & organisation
- Microsoftabout ?overlay=microsoft
Microsoft
Creating sustainability impact for their customers
- Decarbonisation & transitionabout /services/decarbonisation-and-transitionDecarbonisation & transition
- Value creation & commercialisationabout /services/value-creation-and-commercialisationValue creation & commercialisation
- Bluestep Bankabout ?overlay=bluestep-bank
Bluestep Bank
Developing a sustainable strategy for a financial player
- Value creation & commercialisationabout /services/value-creation-and-commercialisationValue creation & commercialisation
- Sustainability strategy & organisationabout /services/sustainability-strategy-and-organisationSustainability strategy & organisation
- Zealand Pharmaabout ?overlay=zealand-pharma
Zealand Pharma
CSRD readiness and ESG Strategy in healthcare
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Sustainability strategy & organisationabout /services/sustainability-strategy-and-organisationSustainability strategy & organisation
- Joe & the Juiceabout ?overlay=joe-and-the-juice
Joe & the Juice
CSRD readiness
- CSDDD & other regulationsabout /services/csddd-and-other-regulationsCSDDD & other regulations
Looking to accelerate your sustainability transition? Take a look at our featured advisory services
Advisory
We partner with companies and organisations to turn sustainability ambitions into measurable, actionable impact.
Zealand Pharma
CSRD readiness and ESG Strategy in healthcare
Zealand Pharma is an international biotechnology company developing innovative peptide-based medicines in three key therapeutic areas: obesity, rare diseases, and chronic inflammation. In preparation for upcoming CSRD requirements and to strengthen its sustainability ambitions, Zealand Pharma partnered with The Footprint Firm to develop a Double Materiality Assessment (DMA) and revisit its ESG strategy, linking regulatory compliance with long-term strategic value.
Services
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Sustainability strategy & organisationabout /services/sustainability-strategy-and-organisationSustainability strategy & organisation
Industries
- Biotechnology
- Pharmaceuticals & healthcare
The project
Zealand Pharma sought to establish a robust Double Materiality Assessment that could serve both as the analytical foundation for compliance and upcoming CSRD reporting and as a strategic tool to inform its ESG direction. The aim was to ensure cross-organisational alignment, engage senior leadership, and use the DMA process to guide the development of an updated, actionable ESG strategy.
Our approach
Working closely with the finance, strategy, and sustainability teams, we facilitated a CSRD-compliant DMA process grounded in stakeholder interviews and engagement with corporate management. The assessment identified material impacts, risks, and opportunities across environmental, social, and governance topics, aligned with CSRD requirements while tailored to Zealand Pharma’s unique context as a biotech innovator.
Building on this foundation, we co-developed an updated ESG strategy structured around three core pillars: Patients, People, and Operations. Each pillar was translated into clear initiatives, measurable targets, and linked CSRD datapoints, ensuring both strategic relevance and reporting readiness.
We also helped map internal ownership by connecting each pillar with relevant data owners and operational leads to embed sustainability across the organisation.
The impact
Our collaboration enabled Zealand Pharma to move from regulatory preparation to strategic integration, delivering a CSRD-ready Double Materiality Assessment and a refreshed ESG strategy rooted in business priorities.
The result: an ESG roadmap that is both compliant and value-generating, with clear internal ownership and a structure that connects Zealand Pharma’s mission to the company’s sustainability performance as a whole.